Top 49 Tekla Capital Management Llc Holdings
| Stock | Company | % Port. | Shares | Value | Activity | Ownership | Avg. Cost | Date |
|---|---|---|---|---|---|---|---|---|
| AMGN | Amgen Inc. | 5.36% | 616.5K | $136.9M | +10.90%(+60.60K) | — | 2023-06-30 | |
| JNJ | Johnson & Johnson | 4.68% | 721.8K | $119.5M | +0.00%(+0) | — | 2023-06-30 | |
| GILD | Gilead Sciences, Inc. | 4.63% | 1.53M | $118.2M | -1.67%(-26.00K) | — | 2023-06-30 | |
| REGN | Regeneron Pharmaceuticals, Inc. | 4.54% | 161.4K | $116.0M | +12.84%(+18.36K) | — | 2023-06-30 | |
| VRTX | Vertex Pharmaceuticals Inc. | 4.38% | 318.0K | $111.9M | -3.72%(-12.30K) | — | 2023-06-30 | |
| LLY | Eli Lilly and Company | 3.92% | 213.4K | $100.1M | -26.15%(-75.56K) | — | 2023-06-30 | |
| UNH | Unitedhealth Group Inc. | 3.89% | 207.0K | $99.5M | -11.62%(-27.21K) | — | 2023-06-30 | |
| MRK | Merck & Co., Inc. | 3.29% | 728.2K | $84.0M | +31.88%(+176.03K) | — | 2023-06-30 | |
| ABBV | AbbVie Inc. | 2.88% | 545.6K | $73.5M | +6.65%(+34.03K) | — | 2023-06-30 | |
| BIIB | Biogen Inc. | 2.76% | 247.9K | $70.6M | +2.91%(+7.02K) | — | 2023-06-30 |
| Performance Metric | 3-Year Annualized | 3-Year Cumulative |
|---|---|---|
| Top 20 Holdings Weighted | — | — |
| Top 20 Holdings Unweighted | — | — |
Sign up free to track Tekla Capital Management Llc, compare funds side by side, and get alerts the moment positions change.